(Press-News.org) ALBUQUERQUE, N.M. — The Sandia Science & Technology Park is being credited with playing a critical role in New Mexico’s economy over the last 25 years, creating high-paying jobs and bringing state-of-the-art technologies to the marketplace.
A study by the Mid-Region Council of Governments shows that over that time, businesses located within the technology park paid out $7.7 billion in wages in the five-county region of Bernalillo, Sandoval, Valencia, Torrance and southern Santa Fe counties. It also shows the park generated more than 6,500 jobs and nearly $4.4 billion in taxable consumer spending as a result of those jobs.
“The Sandia Science & Technology Park is a successful public-private partnership that has thrived for a quarter-century,” said James Peery, Labs Director of Sandia National Laboratories. “Sandia is committed to continuing to grow the park through collaboration, facilitating companies’ access to the Labs’ world-class technologies, expertise and facilities. The goal is to bring high-quality jobs and economic prosperity to the community and the state of New Mexico.”
The technology park was established in 1998 through a partnership between the nonprofit Sandia Science & Technology Park Development Corporation and Sandia National Labs. The collaboration fosters high-wage private-sector job creation through economic partnerships among park companies, Sandia, the Air Force Research Laboratory and the U.S. Space Force.
“The Sandia Science & Technology Park has succeeded in meeting my expectations from when I first helped incorporate the park in 1998,” said Sherman McCorkle, chairman of the SS&TP Development Corp. “The park serves as a valuable technology hub for the state of New Mexico and a driving force for national security development, positioning us at the forefront of growth.”
High-paying, tech-driven employment
The biennial study by Mid-Region Council of Governments looked at not only the number of jobs created but also the quality of those jobs. As of June 2024, there were 42 companies in the park, with 2,038 employees. The average wage of those employees was $92,336.
“We know in America the best jobs in today’s world are technology-based jobs, and this park has the best of technology-based jobs because they work with Sandia National Laboratories, the Air Force Research Laboratory and the new U.S. Space Force,” added McCorkle.
The work performed at the park also helps spur job growth outside of the park. The report shows that 4,375 jobs were linked to the SS&TP in 2022, and 4,528 jobs were linked in 2023. Those jobs were from industries including construction, manufacturing, retail trade, professional and technical services, healthcare and social assistance, accommodation and food services along with various other industries. About half of those were direct employment at the technology park and the other half were indirect.
Regenerating the economy
The technology park also plays a vital role in the local economy through consumer spending. The report analyzed increases in consumer spending and gross regional product attributed to the park and its employees.
Through its 25 years, the park is credited with nearly $4.4 billion in taxable consumer spending in the five-county area. This references the disposable income spent by park employees and their families on goods and services. In 2022 and 2023 alone, that number reached nearly $172 million.
The report also looks at gross regional product, which includes what the businesses in the park spend in the community on things like equipment, goods and services to keep those businesses running. While a cumulative 25-year gross regional product number was not included, in 2022 that number reached more than $429 million, and in 2023 it reached $421 million.
“Since its inception, the Sandia Science & Technology Park has surpassed the expectations of achieving economic competitiveness and prosperity for our local, regional and national economies,” said Dan Sanchez, member of the founding SS&TP community advisory council and assistant manager for programs at the National Nuclear Security Administration’s Sandia site office.
A vision for the future
The future of the technology park continues to look bright. Among the companies that are flourishing is Rocket Lab, which was one of the park’s first residents. Rocket Lab is one of only two companies in the country that specializes in the production of highly efficient and radiation-resistant compound semiconductors used in space to convert light to electricity and power spacecraft. In July, Rocket Lab was awarded up to $23.9 million in funding under the CHIPS and Science Act to expand production of its semiconductors for spacecraft and satellites. This will add more than 100 jobs.
Another park anchor, BlueHalo, which specializes in cutting-edge technology for global defense, was recently awarded a $95.4 million contract for advanced directed energy prototype development by the U.S. Army Space and Missile Defense Command. The contract enables BlueHalo’s continued work to design and build cutting-edge laser weapon systems. The company recently expanded its facilities from 50,000 square feet to more than 200,000 square feet.
The technology park and the City of Albuquerque are also partnering on a second public art project. Artists have the unique opportunity to partner with scientists and innovators to develop a large-scale technology-based public piece of art in the park. The city’s Public Arts Program is funding the $600,000 for the project. The field has been narrowed from 151 applicants to five finalists.
The Sandia Science & Technology Park recently celebrated its 25th anniversary and hopes to mark many more.
“The impact on Sandia is big,” said Mary Monson, senior manager for Technology Partnerships and Business Development at Sandia Labs. “Our suppliers and partners are in the park. We are able to access them easily and they are able to access Sandia. It’s key to our mission success at the Labs. We are a leader in the Department of Energy complex in tech transfer with a $140 billion dollar impact over 20 years, which coincides with the inception and the growth of the park. It has been an important tool for us.”
Media resources available for download
Mid-Region Council of Governments report
Full list of Sandia Science & Technology Park companies and organizations
Mary Monson soundbite 1
Mary Monson soundbite 2
Sherman McCorkle soundbite 1
Sherman McCorkle soundbite 2
Sherman McCorkle soundbite 3
Sandia National Laboratories is a multimission laboratory operated by National Technology and Engineering Solutions of Sandia LLC, a wholly owned subsidiary of Honeywell International Inc., for the U.S. Department of Energy’s National Nuclear Security Administration. Sandia Labs has major research and development responsibilities in nuclear deterrence, global security, defense, energy technologies and economic competitiveness, with main facilities in Albuquerque, New Mexico, and Livermore, California.
Sandia news media contact: Kim Vallez Quintana, kdquint@sandia.gov, 505-537-3294
END
Sandia Science & Technology Park injecting billions into state economy
2024-08-21
ELSE PRESS RELEASES FROM THIS DATE:
Marshall University innovators selected for prestigious NIH-funded entrepreneurship program
2024-08-21
HUNTINGTON, W.Va. – Two Marshall University innovators, Brad Profitt, DC, DPT, DScPT, and M’Hamed Turki, M.D., have been selected to participate in the National Institutes of Health (NIH) funded IDeA Regional Entrepreneurship Development (I-RED) Program, facilitated by the XLerator Network.
The NIH’s competitive I-RED program supports the creation of educational products to promote entrepreneurship in academic institutions. XLerator Health, a health care accelerator based in Louisville, Kentucky, assists startup founders like Profitt and Turki in commercializing their businesses and attracting funding.
Profitt is a co-founder ...
Lipid nanoparticle mRNA therapy improves survival in mouse models of maple syrup urine disease
2024-08-21
New Rochelle, NY, August 21, 2024—Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD). Click here to read the article now.
The researchers, led by James Wilson, M.D., Ph.D., from the University of Pennsylvania, Perelman School of Medicine, evaluated a lipid nanoparticle-based treatment approach to address all possible genetic mutations that can cause MSUD.
“Repeated intravenous ...
USAMMDA commercial partner receives FDA emergency use authorization for plasma powder
2024-08-21
A U.S. Army Medical Materiel Development Activity commercial partner received Emergency Use Authorization from the U.S. Food and Drug Administration for the Department of Defense to use octaplasLG Powder—a potentially lifesaving treatment option for blood replacement therapies in certain operational circumstances. Notice of the EUA for this product was received by the company, Octapharma USA, on Aug. 8, 2024.
USAMMDA’s Warfighter Protection and Acute Care Project Management Office, which has a Cooperative Research and Development Agreement with Octapharma USA, manages research and development efforts for several ...
Pennington Biomedical study to explore effects of soy on blood sugar levels
2024-08-21
Pennington Biomedical Research Center’s Dr. Candida Rebello wants to know more about the intersection of blood sugar levels and a diet rich in soy. This intersection is the primary focus of her new study, “Lifestyle Intervention for Improving Metabolic and Motivational Outcomes,” or MOTIVATE, which explores how specific diets can impact blood sugar, and potentially improve mood and energy levels.
When soy seeds are cut, they produce the anti-microbial compound known as glyceollin, which has been shown to improve insulin sensitivity and cognition. The cut soy seeds will be milled into flour and will be included in the diets of some of the participants. The MOTIVATE ...
Giving an antibiotic to all children under 5 in Africa saves lives
2024-08-21
When UC San Francisco research showed that routinely treating children in Sub-Saharan Africa with a common antibiotic could reduce deaths in children under five, the World Health Organization (WHO) moved quickly to recommend the treatment – but only for infants between 1 and 11 months old.
Now, UCSF researchers have shown that treating babies is not enough. The antibiotic must be given to all children up to 5 years old to realize its full benefit, which is considerable: It lowers child mortality ...
Pivotal study supports belzutifan approval for patients with advanced kidney cancer
2024-08-21
RESEARCH SUMMARY
Study Title: Belzutifan Versus Everolimus for Advanced Renal-Cell Carcinoma
Publication: New England Journal of Medicine, August 22, 2024
Dana-Farber Cancer Institute authors: Toni K. Choueiri, MD
Summary: The LITESPARK-005 phase 3 clinical enrolled 746 patients with metastatic clear cell renal cell carcinoma (ccRCC) who had progressed after treatment with both an immune checkpoint inhibitor (ICI) and an anti-angiogenic therapy. Patients were randomized to receive treatment with either belzutifan, a HIF-2α inhibitor, or everolimus. Overabundant HIF-2α is associated with increased cancer-driving activity. At the second interim analysis of this study, ...
Next time you beat a virus, thank your microbial ancestors
2024-08-21
When you get infected with a virus, some of the first weapons your body deploys to fight it were passed down to us from our microbial ancestors billions of years ago. According to new research from The University of Texas at Austin, two key elements of our innate immune system came from a group of microbes called Asgard archaea.
Specifically, viperins and argonautes, two proteins that are known to play important roles in the immune systems of all complex life — from insects to plants to humans — came from the Asgard archaea. Versions of these defense proteins are also present in bacteria, but the versions in complex life forms are ...
Two UCSB professors selected by the Gordon and Betty Moore Foundation to be Experimental Physics Investigators
2024-08-21
(Santa Barbara, Calif.) — UC Santa Barbara professors Andrew Jayich and Jon Schuller have been selected by the Gordon and Betty Moore Foundation to be part of the 2024 cohort of Experimental Physics Investigators. They join 17 other mid-career researchers from around the country, each receiving a five-year, $1.25 million grant to pursue research goals.
“This initiative is designed to support novel and potentially high-payoff projects that will advance the field of physics but might be hard to fund through traditional funding sources,” said Theodore ...
Study of pythons could lead to new therapies for heart disease, other illnesses
2024-08-21
In the first 24 hours after a python devours its massive prey, its heart grows 25%, its cardiac tissue softens dramatically, and the organ squeezes harder and harder to more than double its pulse. Meanwhile, a vast collection of specialized genes kicks into action to help boost the snake’s metabolism fortyfold. Two weeks later, after its feast has been digested, all systems return to normal—its heart remaining just slightly larger, and even stronger, than before.
This extraordinary process, described by CU Boulder researchers this week in the journal PNAS, could ultimately inspire novel treatments for a common human heart condition called cardiac fibrosis, in which ...
Study finds no link between migraine and Parkinson’s disease
2024-08-21
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, AUGUST 21, 2024
MINNEAPOLIS – Contrary to previous research, a new study of female participants finds no link between migraine and the risk of developing Parkinson’s disease. The study is published in the August 21, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
“These results are reassuring for women who have migraine, which itself causes many burdens, that they don’t have to worry about an increased risk ...